Quipt Home Medical Corp. Files DEFA14A Proxy Materials

TL;DR

Quipt Home Medical Corp. filed proxy docs, no fee needed. Formerly Protech & Patient Home Monitoring.

AI Summary

Quipt Home Medical Corp. filed a Definitive Additional Materials (DEFA14A) on January 29, 2025. This filing relates to the company's proxy statement and indicates no fee was required for this filing. The company was formerly known as Protech Home Medical Corp. and Patient Home Monitoring Corp.

Why It Matters

This filing is a routine regulatory submission for Quipt Home Medical Corp., providing updated proxy information to shareholders and the SEC. It confirms the company's compliance with disclosure requirements.

Risk Assessment

Risk Level: low — This filing is a standard proxy statement update and does not contain new financial information or strategic changes that would inherently increase risk.

Key Numbers

• 20250129 — Filing Date (Date the DEFA14A was filed.)
• 20200714 — Name Change Date (Date Quipt Home Medical Corp. changed from Protech Home Medical Corp.)
• 20120119 — Name Change Date (Date Patient Home Monitoring Corp. changed name.)

Key Players & Entities

• Quipt Home Medical Corp. (company) — Registrant
• Protech Home Medical Corp. (company) — Former Company Name
• Patient Home Monitoring Corp. (company) — Former Company Name
• 0001558370-25-000467 (filing_id) — Accession Number

FAQ

Key Financial Figures

• $75,000 — uch proxy solicitor to be approximately $75,000 for its services in connection with the

Filing Documents

• tmb-20250129xdefa14a.htm (DEFA14A) — 23KB
• 0001558370-25-000467.txt ( ) — 25KB

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 Quipt Home Medical Corp. (Name of Registrant as Specified In Its Charter) Name of Person(s) Filing Proxy Statement, if other than the Registrant Payment of Filing Fee (Check all boxes that apply): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 QUIPT HOME MEDICAL CORP. 1019 Town Drive Wilder, Kentucky 41076 SUPPLEMENT NO. 1 TO MANAGEMENT INFORMATION AND PROXY CIRCULAR FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS OF QUIPT HOME MEDICAL CORP. TO BE HELD ON MARCH 17, 2025 This Supplement No. 1 (this "Supplement"), dated January 29, 2025, supplements, and, to the extent inconsistent, supersedes the Management Information and Proxy Circular (the "Circular"), filed by Quipt Home Medical Corp. (the "Corporation") with the U.S. Securities and Exchange Commission (the "SEC") a nd on the System for Electronic Document Analysis and Retrieval (SEDAR+) at www.sedarplus.com on January 24, 2025 and furnished to Shareholders in connection with the solicitation by management of the Corporation of proxies to be used at the annual general meeting of the holders of common shares of the Corporation to be held on March 17, 2025 at 10:00 a.m. (ET) at the Hampton Inn & Suites, 975 University Parkway, Sarasota, Florida 34243 (including any adjournments, reschedulings, continuations or postponements thereof, the "Meeting"). THIS SUPPLEMENT SHOULD BE READ IN CONJUNCTION WITH THE CIRCULAR, WHICH CONTAINS IMPORTANT ADDITIONAL INFORMATION. Except as to the matters specifically discussed herein, this Supplement does not otherwise modify or update any information or disclosure contained in the Circular. Capitalized terms used but not otherwise defined in this Supplement shall have the meanings assigned to such terms in the Circular. This Supplement is first being sent or given to the Shareholders on January 29, 2025. RECENT DEVELOPMENTS Supplemental Information Regarding the Voting of Proxies On January 25, 2025, the Corporation received a letter pursuant to Rule 14a-19(b) under the Exchange Act ("Rule 14a-19(b)") from Philotimo Fund, LP, an entity affiliated with Kanen Wealth Management, LLC and David L. Kanen (the "Purported Nominating Shareholder") purporting to provide notice (the "14a-19(b) Notice") of such Purported Nominating Shareholder's intent to solicit proxies in support of four director candidates to the Corporation's Board of Directors (the "Board") in opposition to the Corporation's four director candidates to the Board. In addition to satisfying the SEC's universal proxy rules, the Purported Nominating Shareholder must also comply with the advance notice requirements under the Articles (the "Advance Notice Policy") in order to nominate a candidate for election to the Board. The Advance Notice Policy provides that a Shareholder seeking to nominate a candidate for election as a director at any annual meeting of Shareholders must, among other things, give timely and compliant notice thereof in proper written form to the Corporation's Corporate Secretary. The 14a-19(b) Notice did not include the information required under the Advance Notice Policy, and the Corporation has not, as of this date, received a supplement to the 14a-19(b) Notice providing the information required under the Advance Notice Policy. Unless the Corporation receives timely, valid and compliant notice under Rule 14a-19(b) and the Advance Notice Policy, and the Purported Nominating Shareholder otherwise complies with Rule 14a-19 under the Exchange Act ("Rule 14a-19"), any director nominations made by the Purported Nominating Shareholder will not be recognized. Therefore, at this time, the Corporation will not include the names of the Purported Nominating Shareholder's purported nominees on a "universal proxy card." If you are a registered Shareholder and are unable to attend the Meeting, please date and execute the proxy for the Meeting and deposit it with Computershare Investor Services Inc. by (i) mail, Attention: Proxy Department, 8th Floor, 100 University Avenue, Toronto, Ontario M5J 2Y1, (ii) telephone by entering the fifteen digit control number (as found on the Notice of Meeting) at 1 (866) 732-8683 (Canada and the U.S. only) or (312) 588-4290 (outside Canada and the U.S.), or (iii) online by entering the fifteen digit control number (as found on the Notice of Meeting) at www.investorvote.com, before 10:0

View Full Filing

View this DEFA14A filing on SEC EDGAR